Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/Simvastatin vs Atorvastatin in High Risk Hypercholesterolemia
NCT00782184Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe and simvastatin in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: Percent Change From Baseline in Low Density Lipoprotein (LDL)-C at 6 weeks. Started Nov 2008; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00782184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782184.